# Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis.

> **NCT02564471** · PHASE4 · COMPLETED · sponsor: **State University of New York - Upstate Medical University** · enrollment: 103 (actual)

## Conditions studied

- Rabies

## Interventions

- **DRUG:** Chloroquine
- **DRUG:** Atovaquone and Proguanil
- **DRUG:** Doxycycline
- **BIOLOGICAL:** Rabies Vaccine

## Key facts

- **NCT ID:** NCT02564471
- **Lead sponsor:** State University of New York - Upstate Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-11
- **Primary completion:** 2018-08
- **Final completion:** 2019-02
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2021-05-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02564471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02564471, "Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02564471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*